Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bleeding on oral anticoagulants: overview of reversal strategies.
Foletti M, Schmutz T, Fleury Y, Magnin JL, Le Terrier C, Guechi Y. Foletti M, et al. Among authors: le terrier c. Swiss Med Wkly. 2023 Feb 20;153:40036. doi: 10.57187/smw.2023.40036. Swiss Med Wkly. 2023. PMID: 36800887 Free article. Review.
Galère des jeunes médecins : « Less is more »?
Schmutz T, Le Terrier C, Schwaller J, Guechi Y, Ribordy V. Schmutz T, et al. Among authors: le terrier c. Rev Med Suisse. 2023 Dec 20;19(855):2420. doi: 10.53738/REVMED.2023.19.855.2420. Rev Med Suisse. 2023. PMID: 38117117 French. No abstract available.
Flow dynamics.
Schmutz T, Le Terrier C, Ribordy V. Schmutz T, et al. Among authors: le terrier c. Scand J Trauma Resusc Emerg Med. 2024 Jun 27;32(1):59. doi: 10.1186/s13049-024-01232-y. Scand J Trauma Resusc Emerg Med. 2024. PMID: 38937831 Free PMC article. No abstract available.
NDM-9 resistance to taniborbactam.
Le Terrier C, Gruenig V, Fournier C, Nordmann P, Poirel L. Le Terrier C, et al. Lancet Infect Dis. 2023 Apr;23(4):401-402. doi: 10.1016/S1473-3099(23)00069-5. Epub 2023 Feb 13. Lancet Infect Dis. 2023. PMID: 36796395 No abstract available.
In-vitro activity of the novel β-lactam/β-lactamase inhibitor combinations and cefiderocol against carbapenem-resistant Pseudomonas spp. clinical isolates collected in Switzerland in 2022.
Le Terrier C, Bouvier M, Kerbol A, Dell'Acqua C; Nara Network members; Nordmann P, Poirel L. Le Terrier C, et al. Eur J Clin Microbiol Infect Dis. 2024 Dec 20. doi: 10.1007/s10096-024-04994-6. Online ahead of print. Eur J Clin Microbiol Infect Dis. 2024. PMID: 39704920
In-vitro activity of newly-developed β-lactamase inhibitors avibactam, relebactam and vaborbactam in combination with anti-pseudomonal β-lactam antibiotics against AmpC-overproducing clinical Pseudomonas aeruginosa isolates.
Le Terrier C, Raro OHF, Saad AM, Nordmann P, Poirel L. Le Terrier C, et al. Eur J Clin Microbiol Infect Dis. 2024 Nov 26. doi: 10.1007/s10096-024-04965-x. Online ahead of print. Eur J Clin Microbiol Infect Dis. 2024. PMID: 39589655
59 results